Edition:
United States

Fulgent Genetics Inc (FLGT.OQ)

FLGT.OQ on NASDAQ Stock Exchange Global Market

3.47USD
15 Dec 2017
Change (% chg)

$0.07 (+2.06%)
Prev Close
$3.40
Open
$3.40
Day's High
$3.55
Day's Low
$3.40
Volume
15,228
Avg. Vol
13,722
52-wk High
$13.80
52-wk Low
$2.73

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.04 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 3 3
(3) HOLD 1 1 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 5.12 5.26 5.00 10.75
Quarter Ending Mar-18 3 6.38 8.06 5.40 12.25
Year Ending Dec-17 3 19.58 19.71 19.50 36.13
Year Ending Dec-18 3 26.92 30.61 24.60 54.46
Earnings (per share)
Quarter Ending Dec-17 2 -0.04 -0.02 -0.05 0.14
Quarter Ending Mar-18 2 -0.03 -0.01 -0.04 0.17
Year Ending Dec-17 3 -0.04 0.04 -0.10 0.43
Year Ending Dec-18 3 0.02 0.19 -0.13 0.72

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5.61 4.50 1.11 19.75
Quarter Ending Jun-17 4.81 4.64 0.17 3.59
Quarter Ending Mar-17 6.34 5.31 1.04 16.34
Quarter Ending Dec-16 6.02 5.85 0.17 2.79
Quarter Ending Sep-16 5.02 5.01 0.01 0.21

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 5.12 5.12 5.12 8.00 10.75
Quarter Ending Mar-18 6.38 6.38 6.38 8.03 12.25
Year Ending Dec-17 19.58 19.58 19.58 23.54 36.13
Year Ending Dec-18 26.92 26.92 26.92 35.49 54.46

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings